Lotus Eye Hospital And Institute Ltd (IN:LOTUSEYE)
:LOTUSEYE
Want to see IN:LOTUSEYE full AI Analyst Report?
LOTUSEYE Stock Chart & Stats
₹118.10
-₹0.92(-1.30%)
At close: 4:00 PM EST
₹118.10
-₹0.92(-1.30%)
Day’s Range― - ―
52-Week Range₹68.00 - ₹147.60
Previous CloseN/A
Volume15.88K
Average Volume (3M)2.23K
Market Cap
₹2.51B
Enterprise Value₹2.56B
Total Cash (Recent Filing)₹32.49M
Total Debt (Recent Filing)₹47.99M
Price to Earnings (P/E)―
Beta0.88
Next Earnings
May 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding20,796,330
10 Day Avg. Volume4,541
30 Day Avg. Volume2,230
Financial Highlights & Ratios
PEG Ratio-2.60
Price to Book (P/B)2.43
Price to Sales (P/S)2.94
P/FCF Ratio-68.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthA large equity base and low leverage provide a durable financial foundation. This reduces refinancing risk, supports capital allocation for new centres or equipment, and gives management flexibility to absorb demand shocks or pursue strategic investments without immediate pressure on cash flows.
Steady Revenue GrowthConsistent multi-year revenue growth signals expanding patient volumes and service uptake, reflecting structural demand for ophthalmology services. Sustainable top-line expansion supports scale economics, fixed-cost absorption across centres, and a platform for long-term margin recovery if cost control follows.
Operating Cash Flow GenerationPositive operating cash flow indicates the core eye-care business converts revenue into cash sustainably. That cash generation underpins working capital, funds routine investments, and limits short-term financing needs, improving the company's resilience while it executes growth and capex plans.
Bears Say
Margin CompressionA sharp, sustained decline in gross and net margins points to structural cost pressure or pricing erosion. If persistent, lower margins reduce free cash flow potential, limit reinvestment capacity, and weaken returns on new clinics or surgical services, making growth less accretive to shareholder value.
Negative Free Cash Flow / High CapexPersistent negative free cash flow from elevated capex suggests aggressive expansion or equipment spend that outpaces cash generation. If revenue and margins don't scale quickly, the company may face liquidity pressure or need external funding, increasing execution and financing risk over the medium term.
Rising Liabilities (Equity Ratio Decline)A declining equity ratio, even from a strong base, signals liabilities growing faster than equity. Over time this erodes financial buffers, reducing flexibility to absorb shocks or fund new investments internally, and could constrain management options if capital needs rise.
Lotus Eye Hospital And Institute Ltd News
LOTUSEYE FAQ
What was Lotus Eye Hospital And Institute Ltd’s price range in the past 12 months?
Lotus Eye Hospital And Institute Ltd lowest stock price was ₹68.00 and its highest was ₹147.60 in the past 12 months.
What is Lotus Eye Hospital And Institute Ltd’s market cap?
Lotus Eye Hospital And Institute Ltd’s market cap is ₹2.51B.
When is Lotus Eye Hospital And Institute Ltd’s upcoming earnings report date?
Lotus Eye Hospital And Institute Ltd’s upcoming earnings report date is May 27, 2026 which is in 26 days.
How were Lotus Eye Hospital And Institute Ltd’s earnings last quarter?
Lotus Eye Hospital And Institute Ltd released its earnings results on Feb 11, 2026. The company reported -₹0.125 earnings per share for the quarter, missing the consensus estimate of N/A by -₹0.125.
Is Lotus Eye Hospital And Institute Ltd overvalued?
According to Wall Street analysts Lotus Eye Hospital And Institute Ltd’s price is currently Overvalued.
Does Lotus Eye Hospital And Institute Ltd pay dividends?
Lotus Eye Hospital And Institute Ltd pays a Annually dividend of ₹0.5 which represents an annual dividend yield of N/A. See more information on Lotus Eye Hospital And Institute Ltd dividends here
What is Lotus Eye Hospital And Institute Ltd’s EPS estimate?
Lotus Eye Hospital And Institute Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lotus Eye Hospital And Institute Ltd have?
Lotus Eye Hospital And Institute Ltd has 20,796,330 shares outstanding.
What happened to Lotus Eye Hospital And Institute Ltd’s price movement after its last earnings report?
Lotus Eye Hospital And Institute Ltd reported an EPS of -₹0.125 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.112%.
Which hedge fund is a major shareholder of Lotus Eye Hospital And Institute Ltd?
Currently, no hedge funds are holding shares in IN:LOTUSEYE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Lotus Eye Hospital And Institute Ltd
Lotus Eye Hospital and Institute Limited, an eye hospital, provides eye care services in India. It offers services in the areas of refractive surgery, retina and uvea, cornea, glaucoma, paediatric and squint, computer vision syndrome, orbit and oculoplasty, neuro ophthalmology, and binocular vision. The company also provides cataract and intraocular lenses, as well as operates an eye bank. In addition, it offers ophthalmic fellowship training courses in cornea, glaucoma, retina, and anterior segments, as well as DNB teaching and training services. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was incorporated in 1997 and is based in Coimbatore, India.
Technical Analysis
Apollo Hospitals Enterprise Limited
―
Aster DM Healthcare Ltd.
―
Fortis Healthcare Ltd.
―
Max Healthcare Institute Ltd
―
Global Health Limited
―